Aims & Scope


OMICS: A Journal of Integrative Biology is the only peer-reviewed journal covering all trans-disciplinary OMICs-related areas, including data standards and sharing; applications for personalized medicine and public health practice; and social, legal, and ethics analysis. The Journal integrates global high-throughput and systems approaches to 21st century science from “cell to society” – seen from a post-genomics perspective.

In addition, OMICS encourages submission of reports on methods and resources underpinning integrative research, including but not limited to bioinformatics, computational biology, and biomedical informatics; data standards, meta-data, data sharing, databases, biobanks and cloud computing; methodological, statistical, and algorithmic developments; capacity building for developing world OMICS; applications of OMICS for personalized medicine (e.g., pharmacogenomics) and public health practice (e.g., vaccinomics); and social, legal and ethics analyses of OMICS technologies and post-genomics life science innovations.

OMICS: A Journal of Integrative Biology coverage includes:

  • All Omics Fields including Multi-Omics Science
  • Integrative Biology
  • Genomics
  • Proteomics
  • Metabolomics
  • Metagenomics
  • Transcriptomics
  • Personalized Medicine
  • Pharmacogenomics 
  • Nutrigenomics
  • Theranostics
  • Biomarkers, Drug Discovery and Development
  • Microbial Omics
  • Diagnostic Medicine
  • Ecology and Environmental Omics
  • Implementation Science and Omics
  • Omics Technology Policy
  • Responsible Innovation, OMICS & Society Research

OMICS: A Journal of Integrative Biology is under the editorial leadership of Editor-in-Chief Vural Özdemir, MD, PhD, DABCP, Adjunct Professor, School of Biotechnology, Amrita University, Kerala, India, and Independent Writer and Researcher, Technology, Society & Democracy, Toronto, Ontario, Canada, and other leading investigators. View the entire editorial board.

Audience: Integrative biology and multi-omics system scientists; Precision medicine (pharmacogenomics, nutrigenomics, vaccinomics, theranostics) scholars; Medical doctors, nurses, health researchers, patients, engineers and policymakers interested in large scale biology and systems sciences; Bioinformaticians and computational biologists; Biotechnology industry; Scholars in societal and ethical aspects of emerging technologies; among others.

Indexed/Abstracted in:

MEDLINE;

PubMed;

PubMed Central;

Current Contents®/Life Sciences;

Science Citation Index Expanded;

Science Citation Index®;

Biotechnology Citation Index®;

Biochemistry & Biophysics Citation Index®;

Biological Abstracts;

BIOSIS Previews;

Journal Citation Reports/Science Edition;

EMBASE/Excerpta Medica;

EMBiology;

Scopus;

ProQuest databases;

CAB Abstracts;

Global Health;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.